Nektar Therapeutics (NKTR) ROE US GAAP (year values) |
||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
ROE, % | ? | -41.3% | -77.1% | -100.4% | -100.4% | -210.8% | -138.8% | |
Changes by years, y/y, % | -10pp | -36pp | -23pp | 0pp | -110pp |
Nektar Therapeutics. ROE, %
Nektar Therapeutics. ROE, changes, pp
Nektar Therapeutics (NKTR) ROE US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
ROE, % | ? | -172.2% | -155.8% | -184.3% | -210.8% | -138.8% | -138.8% | |
Changes by years, y/y, % | -91pp | -41pp | -74pp | -110pp | +33pp | |||
Changes by quarters, q/q, % | -72pp | +16pp | -28pp | -26pp | +72pp |